NEW YORK, June 22, 2016 /PRNewswire/ --
Growth is expected for the U.S. Medical Appliances and Equipment
industry as demand for healthcare continues to rise. In today's
pre-market research, Stock-Callers.com shifts its attention on
these four equities for investors' close review: Align Technology
Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica
Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM).
Learn more about these stocks and receive your complimentary trade
alerts at:
http://stock-callers.com/registration
To access Stock-Callers.com full PDF Research
Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
ALGN Research
Package: http://stock-callers.com/registration/?symbol=ALGN
ZLTQ Research
Package: http://stock-callers.com/registration/?symbol=ZLTQ
AMDA Research
Package: http://stock-callers.com/registration/?symbol=AMDA
NXTM Research
Package: http://stock-callers.com/registration/?symbol=NXTM
At the close on Tuesday, shares in San
Jose, California headquartered Align Technology Inc. saw a
slight decline of 0.41%, ending the day at $79.34. The stock recorded a trading volume of
627,240 shares. The Company's shares have advanced 2.47% in the
last one month, 13.64% in the previous three months, and 20.49%
since the start of this year. The stock is trading above its 50-day
and 200-day moving averages by 3.85% and 18.19%, respectively.
Moreover, shares of Align Technology, which designs, manufactures,
and markets a system of clear aligner therapy, intra-oral scanners,
and computer-aided design and computer-aided manufacturing digital
services for use in dentistry, orthodontics, and dental records
storage globally, have a Relative Strength Index (RSI) of
58.82.
Shares in Pleasanton,
California headquartered medical technology Company, ZELTIQ
Aesthetics Inc. ended the day 2.52% lower at $27.06. A total volume of 744,216 shares was
traded, which was above their three months average volume of
693,230 shares. In the last month and the previous three months,
the stock has gained 7.21% and 8.81%, respectively. The Company's
shares are trading below their 50-day moving average by 4.39%.
Furthermore, shares of ZELTIQ Aesthetics, which engages in
developing and commercializing non-invasive products for the
selective reduction of fat, have an RSI of 40.72.
On Tuesday, shares in Salt Lake City,
Utah headquartered commercial-stage biomaterial Company,
Amedica Corp., finished flat at $1.26
and with a total volume of 169,192 shares traded. The stock is
trading below its 50-day moving average by 14.59%. Shares of the
Company, which develops, manufactures, and sells a range of medical
devices based on its silicon nitride ceramic technology platform in
the U.S., Europe, and South America, have an RSI of 36.15.
Lawrence, Massachusetts
headquartered medical technology Company, Nxstage Medical Inc.'s
shares recorded a trading volume of 539,041 shares at the end of
yesterday's session and closed the day at $19.92, which was a slight drop of 0.05%. The
stock has advanced 10.61% in the last one month and 35.97% in the
previous three months. The Company's shares are trading above their
50-day and 200-day moving averages by 11.93% and 13.53%,
respectively. Additionally, shares of Nxstage Medical, which
develops, manufactures, and markets products and services for
patients suffering from chronic or acute kidney failure, have an
RSI at 56.94.
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored
reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and
micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
SC has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither SC nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street,
Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA